News-Medical.Net on MSN
Tufts researchers identify new vulnerabilities to combat persistent C. diff infections
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile —commonly known as C. diff —are a serious and persistent problem for patients and ...
As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new ...
Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...
AstraZeneca (AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase IIb study titled “A Phase IIb, Randomized, Double-blind, Placebo-controlled Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results